Globus Medical Inc <GMED.N>: UBS Initiates Coverage With Neutral Rating; Target Price $82
GMED•Related News
Oman proposes Hormuz management system with voluntary fees, source says
XLE•
Enovis Corp <ENOV.N>: UBS assumes coverage with Buy rating; target price $51 vs $50
ENOV•
Xylem gains after annual profit forecast raise
XYL•
Constellation Energy Corp <CEG.O>: UBS cuts target price to $380 from $388
CEG•
EBay, former executives to pay $56 million to settle couple's harassment case
EBAY•